nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—ABCB1—Mitomycin—urinary bladder cancer	0.387	0.505	CbGbCtD
Sofosbuvir—ABCB1—Gemcitabine—urinary bladder cancer	0.111	0.145	CbGbCtD
Sofosbuvir—ABCB1—Cisplatin—urinary bladder cancer	0.0809	0.106	CbGbCtD
Sofosbuvir—ABCB1—Etoposide—urinary bladder cancer	0.0795	0.104	CbGbCtD
Sofosbuvir—ABCB1—Doxorubicin—urinary bladder cancer	0.0542	0.0708	CbGbCtD
Sofosbuvir—ABCB1—Methotrexate—urinary bladder cancer	0.0525	0.0686	CbGbCtD
Sofosbuvir—Anaemia—Fluorouracil—urinary bladder cancer	0.000722	0.00307	CcSEcCtD
Sofosbuvir—Muscle spasms—Cisplatin—urinary bladder cancer	0.000712	0.00303	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Etoposide—urinary bladder cancer	0.000703	0.00299	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.000703	0.00299	CcSEcCtD
Sofosbuvir—Chills—Etoposide—urinary bladder cancer	0.0007	0.00298	CcSEcCtD
Sofosbuvir—Vision blurred—Cisplatin—urinary bladder cancer	0.000698	0.00297	CcSEcCtD
Sofosbuvir—Cough—Gemcitabine—urinary bladder cancer	0.000694	0.00295	CcSEcCtD
Sofosbuvir—Alopecia—Etoposide—urinary bladder cancer	0.000689	0.00293	CcSEcCtD
Sofosbuvir—Anaemia—Cisplatin—urinary bladder cancer	0.000685	0.00291	CcSEcCtD
Sofosbuvir—Dyspepsia—Thiotepa—urinary bladder cancer	0.000679	0.00289	CcSEcCtD
Sofosbuvir—Chest pain—Gemcitabine—urinary bladder cancer	0.000677	0.00288	CcSEcCtD
Sofosbuvir—Arthralgia—Gemcitabine—urinary bladder cancer	0.000677	0.00288	CcSEcCtD
Sofosbuvir—Myalgia—Gemcitabine—urinary bladder cancer	0.000677	0.00288	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000672	0.00286	CcSEcCtD
Sofosbuvir—Decreased appetite—Thiotepa—urinary bladder cancer	0.00067	0.00285	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000666	0.00283	CcSEcCtD
Sofosbuvir—Myalgia—Fluorouracil—urinary bladder cancer	0.000665	0.00283	CcSEcCtD
Sofosbuvir—Chest pain—Fluorouracil—urinary bladder cancer	0.000665	0.00283	CcSEcCtD
Sofosbuvir—Fatigue—Thiotepa—urinary bladder cancer	0.000665	0.00283	CcSEcCtD
Sofosbuvir—Pain—Thiotepa—urinary bladder cancer	0.00066	0.00281	CcSEcCtD
Sofosbuvir—Constipation—Thiotepa—urinary bladder cancer	0.00066	0.00281	CcSEcCtD
Sofosbuvir—Back pain—Etoposide—urinary bladder cancer	0.000657	0.00279	CcSEcCtD
Sofosbuvir—Muscle spasms—Etoposide—urinary bladder cancer	0.000653	0.00278	CcSEcCtD
Sofosbuvir—Infection—Gemcitabine—urinary bladder cancer	0.000645	0.00274	CcSEcCtD
Sofosbuvir—Irritability—Methotrexate—urinary bladder cancer	0.000644	0.00274	CcSEcCtD
Sofosbuvir—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000636	0.00271	CcSEcCtD
Sofosbuvir—Infection—Fluorouracil—urinary bladder cancer	0.000634	0.0027	CcSEcCtD
Sofosbuvir—Myalgia—Cisplatin—urinary bladder cancer	0.000631	0.00268	CcSEcCtD
Sofosbuvir—Skin disorder—Gemcitabine—urinary bladder cancer	0.00063	0.00268	CcSEcCtD
Sofosbuvir—Anxiety—Cisplatin—urinary bladder cancer	0.000629	0.00267	CcSEcCtD
Sofosbuvir—Anaemia—Etoposide—urinary bladder cancer	0.000627	0.00267	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000627	0.00267	CcSEcCtD
Sofosbuvir—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.000626	0.00266	CcSEcCtD
Sofosbuvir—Migraine—Epirubicin—urinary bladder cancer	0.000622	0.00265	CcSEcCtD
Sofosbuvir—Body temperature increased—Thiotepa—urinary bladder cancer	0.00061	0.00259	CcSEcCtD
Sofosbuvir—Infection—Cisplatin—urinary bladder cancer	0.000601	0.00256	CcSEcCtD
Sofosbuvir—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000593	0.00252	CcSEcCtD
Sofosbuvir—Cough—Etoposide—urinary bladder cancer	0.000592	0.00252	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000591	0.00252	CcSEcCtD
Sofosbuvir—Skin disorder—Cisplatin—urinary bladder cancer	0.000587	0.0025	CcSEcCtD
Sofosbuvir—Insomnia—Gemcitabine—urinary bladder cancer	0.000587	0.0025	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000581	0.00247	CcSEcCtD
Sofosbuvir—Dry skin—Epirubicin—urinary bladder cancer	0.000579	0.00246	CcSEcCtD
Sofosbuvir—Dyspnoea—Gemcitabine—urinary bladder cancer	0.000578	0.00246	CcSEcCtD
Sofosbuvir—Chest pain—Etoposide—urinary bladder cancer	0.000578	0.00246	CcSEcCtD
Sofosbuvir—Insomnia—Fluorouracil—urinary bladder cancer	0.000577	0.00246	CcSEcCtD
Sofosbuvir—Migraine—Doxorubicin—urinary bladder cancer	0.000575	0.00245	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000574	0.00244	CcSEcCtD
Sofosbuvir—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000569	0.00242	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000565	0.0024	CcSEcCtD
Sofosbuvir—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000564	0.0024	CcSEcCtD
Sofosbuvir—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000562	0.00239	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00056	0.00238	CcSEcCtD
Sofosbuvir—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000559	0.00238	CcSEcCtD
Sofosbuvir—Fatigue—Gemcitabine—urinary bladder cancer	0.000559	0.00238	CcSEcCtD
Sofosbuvir—Constipation—Gemcitabine—urinary bladder cancer	0.000555	0.00236	CcSEcCtD
Sofosbuvir—Pain—Gemcitabine—urinary bladder cancer	0.000555	0.00236	CcSEcCtD
Sofosbuvir—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000555	0.00236	CcSEcCtD
Sofosbuvir—Pancytopenia—Methotrexate—urinary bladder cancer	0.000554	0.00236	CcSEcCtD
Sofosbuvir—Asthenia—Thiotepa—urinary bladder cancer	0.000553	0.00235	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000551	0.00234	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000551	0.00234	CcSEcCtD
Sofosbuvir—Infection—Etoposide—urinary bladder cancer	0.00055	0.00234	CcSEcCtD
Sofosbuvir—Neutropenia—Methotrexate—urinary bladder cancer	0.000546	0.00232	CcSEcCtD
Sofosbuvir—Pruritus—Thiotepa—urinary bladder cancer	0.000546	0.00232	CcSEcCtD
Sofosbuvir—Pain—Fluorouracil—urinary bladder cancer	0.000546	0.00232	CcSEcCtD
Sofosbuvir—Dyspnoea—Cisplatin—urinary bladder cancer	0.000539	0.00229	CcSEcCtD
Sofosbuvir—Skin disorder—Etoposide—urinary bladder cancer	0.000538	0.00229	CcSEcCtD
Sofosbuvir—Dry skin—Doxorubicin—urinary bladder cancer	0.000536	0.00228	CcSEcCtD
Sofosbuvir—Diarrhoea—Thiotepa—urinary bladder cancer	0.000528	0.00225	CcSEcCtD
Sofosbuvir—Decreased appetite—Cisplatin—urinary bladder cancer	0.000526	0.00224	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000523	0.00222	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000522	0.00222	CcSEcCtD
Sofosbuvir—Infestation NOS—Methotrexate—urinary bladder cancer	0.00052	0.00221	CcSEcCtD
Sofosbuvir—Infestation—Methotrexate—urinary bladder cancer	0.00052	0.00221	CcSEcCtD
Sofosbuvir—Pancytopenia—Epirubicin—urinary bladder cancer	0.000519	0.00221	CcSEcCtD
Sofosbuvir—Pain—Cisplatin—urinary bladder cancer	0.000517	0.0022	CcSEcCtD
Sofosbuvir—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000513	0.00218	CcSEcCtD
Sofosbuvir—Neutropenia—Epirubicin—urinary bladder cancer	0.000511	0.00217	CcSEcCtD
Sofosbuvir—Dizziness—Thiotepa—urinary bladder cancer	0.00051	0.00217	CcSEcCtD
Sofosbuvir—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000504	0.00215	CcSEcCtD
Sofosbuvir—Weight decreased—Epirubicin—urinary bladder cancer	0.000494	0.0021	CcSEcCtD
Sofosbuvir—Dyspnoea—Etoposide—urinary bladder cancer	0.000494	0.0021	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000492	0.00209	CcSEcCtD
Sofosbuvir—Vomiting—Thiotepa—urinary bladder cancer	0.00049	0.00209	CcSEcCtD
Sofosbuvir—Infestation NOS—Epirubicin—urinary bladder cancer	0.000487	0.00207	CcSEcCtD
Sofosbuvir—Infestation—Epirubicin—urinary bladder cancer	0.000487	0.00207	CcSEcCtD
Sofosbuvir—Rash—Thiotepa—urinary bladder cancer	0.000486	0.00207	CcSEcCtD
Sofosbuvir—Dermatitis—Thiotepa—urinary bladder cancer	0.000486	0.00207	CcSEcCtD
Sofosbuvir—Headache—Thiotepa—urinary bladder cancer	0.000483	0.00206	CcSEcCtD
Sofosbuvir—Decreased appetite—Etoposide—urinary bladder cancer	0.000482	0.00205	CcSEcCtD
Sofosbuvir—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00048	0.00204	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000478	0.00204	CcSEcCtD
Sofosbuvir—Body temperature increased—Cisplatin—urinary bladder cancer	0.000478	0.00203	CcSEcCtD
Sofosbuvir—Fatigue—Etoposide—urinary bladder cancer	0.000478	0.00203	CcSEcCtD
Sofosbuvir—Pain—Etoposide—urinary bladder cancer	0.000474	0.00202	CcSEcCtD
Sofosbuvir—Constipation—Etoposide—urinary bladder cancer	0.000474	0.00202	CcSEcCtD
Sofosbuvir—Neutropenia—Doxorubicin—urinary bladder cancer	0.000473	0.00201	CcSEcCtD
Sofosbuvir—Asthenia—Gemcitabine—urinary bladder cancer	0.000466	0.00198	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000461	0.00196	CcSEcCtD
Sofosbuvir—Pruritus—Gemcitabine—urinary bladder cancer	0.000459	0.00195	CcSEcCtD
Sofosbuvir—Nausea—Thiotepa—urinary bladder cancer	0.000458	0.00195	CcSEcCtD
Sofosbuvir—Weight decreased—Doxorubicin—urinary bladder cancer	0.000457	0.00195	CcSEcCtD
Sofosbuvir—Pruritus—Fluorouracil—urinary bladder cancer	0.000451	0.00192	CcSEcCtD
Sofosbuvir—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000451	0.00192	CcSEcCtD
Sofosbuvir—Infestation—Doxorubicin—urinary bladder cancer	0.000451	0.00192	CcSEcCtD
Sofosbuvir—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000444	0.00189	CcSEcCtD
Sofosbuvir—Body temperature increased—Etoposide—urinary bladder cancer	0.000438	0.00186	CcSEcCtD
Sofosbuvir—Eye disorder—Methotrexate—urinary bladder cancer	0.000437	0.00186	CcSEcCtD
Sofosbuvir—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000436	0.00186	CcSEcCtD
Sofosbuvir—Asthenia—Cisplatin—urinary bladder cancer	0.000434	0.00185	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00043	0.00183	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000426	0.00181	CcSEcCtD
Sofosbuvir—Dizziness—Fluorouracil—urinary bladder cancer	0.000422	0.00179	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000421	0.00179	CcSEcCtD
Sofosbuvir—Chills—Methotrexate—urinary bladder cancer	0.000419	0.00178	CcSEcCtD
Sofosbuvir—Diarrhoea—Cisplatin—urinary bladder cancer	0.000414	0.00176	CcSEcCtD
Sofosbuvir—Alopecia—Methotrexate—urinary bladder cancer	0.000413	0.00176	CcSEcCtD
Sofosbuvir—Vomiting—Gemcitabine—urinary bladder cancer	0.000413	0.00176	CcSEcCtD
Sofosbuvir—Rash—Gemcitabine—urinary bladder cancer	0.000409	0.00174	CcSEcCtD
Sofosbuvir—Dermatitis—Gemcitabine—urinary bladder cancer	0.000409	0.00174	CcSEcCtD
Sofosbuvir—Eye disorder—Epirubicin—urinary bladder cancer	0.000409	0.00174	CcSEcCtD
Sofosbuvir—Malnutrition—Methotrexate—urinary bladder cancer	0.000407	0.00173	CcSEcCtD
Sofosbuvir—Headache—Gemcitabine—urinary bladder cancer	0.000406	0.00173	CcSEcCtD
Sofosbuvir—Vomiting—Fluorouracil—urinary bladder cancer	0.000406	0.00173	CcSEcCtD
Sofosbuvir—Rash—Fluorouracil—urinary bladder cancer	0.000402	0.00171	CcSEcCtD
Sofosbuvir—Dermatitis—Fluorouracil—urinary bladder cancer	0.000402	0.00171	CcSEcCtD
Sofosbuvir—Headache—Fluorouracil—urinary bladder cancer	0.0004	0.0017	CcSEcCtD
Sofosbuvir—Asthenia—Etoposide—urinary bladder cancer	0.000398	0.00169	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000397	0.00169	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000394	0.00168	CcSEcCtD
Sofosbuvir—Back pain—Methotrexate—urinary bladder cancer	0.000393	0.00167	CcSEcCtD
Sofosbuvir—Chills—Epirubicin—urinary bladder cancer	0.000392	0.00167	CcSEcCtD
Sofosbuvir—Pruritus—Etoposide—urinary bladder cancer	0.000392	0.00167	CcSEcCtD
Sofosbuvir—Alopecia—Epirubicin—urinary bladder cancer	0.000386	0.00164	CcSEcCtD
Sofosbuvir—Nausea—Gemcitabine—urinary bladder cancer	0.000385	0.00164	CcSEcCtD
Sofosbuvir—Vomiting—Cisplatin—urinary bladder cancer	0.000385	0.00164	CcSEcCtD
Sofosbuvir—Vision blurred—Methotrexate—urinary bladder cancer	0.000383	0.00163	CcSEcCtD
Sofosbuvir—Rash—Cisplatin—urinary bladder cancer	0.000381	0.00162	CcSEcCtD
Sofosbuvir—Dermatitis—Cisplatin—urinary bladder cancer	0.000381	0.00162	CcSEcCtD
Sofosbuvir—Malnutrition—Epirubicin—urinary bladder cancer	0.000381	0.00162	CcSEcCtD
Sofosbuvir—Diarrhoea—Etoposide—urinary bladder cancer	0.000379	0.00161	CcSEcCtD
Sofosbuvir—Nausea—Fluorouracil—urinary bladder cancer	0.000379	0.00161	CcSEcCtD
Sofosbuvir—Eye disorder—Doxorubicin—urinary bladder cancer	0.000378	0.00161	CcSEcCtD
Sofosbuvir—Anaemia—Methotrexate—urinary bladder cancer	0.000376	0.0016	CcSEcCtD
Sofosbuvir—Back pain—Epirubicin—urinary bladder cancer	0.000368	0.00157	CcSEcCtD
Sofosbuvir—Dizziness—Etoposide—urinary bladder cancer	0.000366	0.00156	CcSEcCtD
Sofosbuvir—Muscle spasms—Epirubicin—urinary bladder cancer	0.000366	0.00156	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000365	0.00155	CcSEcCtD
Sofosbuvir—Chills—Doxorubicin—urinary bladder cancer	0.000363	0.00154	CcSEcCtD
Sofosbuvir—Nausea—Cisplatin—urinary bladder cancer	0.000359	0.00153	CcSEcCtD
Sofosbuvir—Vision blurred—Epirubicin—urinary bladder cancer	0.000359	0.00153	CcSEcCtD
Sofosbuvir—Alopecia—Doxorubicin—urinary bladder cancer	0.000357	0.00152	CcSEcCtD
Sofosbuvir—Cough—Methotrexate—urinary bladder cancer	0.000355	0.00151	CcSEcCtD
Sofosbuvir—Vomiting—Etoposide—urinary bladder cancer	0.000352	0.0015	CcSEcCtD
Sofosbuvir—Malnutrition—Doxorubicin—urinary bladder cancer	0.000352	0.0015	CcSEcCtD
Sofosbuvir—Anaemia—Epirubicin—urinary bladder cancer	0.000352	0.0015	CcSEcCtD
Sofosbuvir—Agitation—Epirubicin—urinary bladder cancer	0.00035	0.00149	CcSEcCtD
Sofosbuvir—Rash—Etoposide—urinary bladder cancer	0.000349	0.00149	CcSEcCtD
Sofosbuvir—Dermatitis—Etoposide—urinary bladder cancer	0.000349	0.00148	CcSEcCtD
Sofosbuvir—Headache—Etoposide—urinary bladder cancer	0.000347	0.00148	CcSEcCtD
Sofosbuvir—Arthralgia—Methotrexate—urinary bladder cancer	0.000346	0.00147	CcSEcCtD
Sofosbuvir—Chest pain—Methotrexate—urinary bladder cancer	0.000346	0.00147	CcSEcCtD
Sofosbuvir—Myalgia—Methotrexate—urinary bladder cancer	0.000346	0.00147	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000344	0.00146	CcSEcCtD
Sofosbuvir—Back pain—Doxorubicin—urinary bladder cancer	0.000341	0.00145	CcSEcCtD
Sofosbuvir—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000339	0.00144	CcSEcCtD
Sofosbuvir—Cough—Epirubicin—urinary bladder cancer	0.000332	0.00141	CcSEcCtD
Sofosbuvir—Vision blurred—Doxorubicin—urinary bladder cancer	0.000332	0.00141	CcSEcCtD
Sofosbuvir—Infection—Methotrexate—urinary bladder cancer	0.00033	0.0014	CcSEcCtD
Sofosbuvir—Nausea—Etoposide—urinary bladder cancer	0.000329	0.0014	CcSEcCtD
Sofosbuvir—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000325	0.00138	CcSEcCtD
Sofosbuvir—Anaemia—Doxorubicin—urinary bladder cancer	0.000325	0.00138	CcSEcCtD
Sofosbuvir—Arthralgia—Epirubicin—urinary bladder cancer	0.000324	0.00138	CcSEcCtD
Sofosbuvir—Myalgia—Epirubicin—urinary bladder cancer	0.000324	0.00138	CcSEcCtD
Sofosbuvir—Chest pain—Epirubicin—urinary bladder cancer	0.000324	0.00138	CcSEcCtD
Sofosbuvir—Agitation—Doxorubicin—urinary bladder cancer	0.000324	0.00138	CcSEcCtD
Sofosbuvir—Anxiety—Epirubicin—urinary bladder cancer	0.000323	0.00137	CcSEcCtD
Sofosbuvir—Skin disorder—Methotrexate—urinary bladder cancer	0.000322	0.00137	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000322	0.00137	CcSEcCtD
Sofosbuvir—Dry mouth—Epirubicin—urinary bladder cancer	0.000317	0.00135	CcSEcCtD
Sofosbuvir—Infection—Epirubicin—urinary bladder cancer	0.000309	0.00131	CcSEcCtD
Sofosbuvir—Cough—Doxorubicin—urinary bladder cancer	0.000307	0.00131	CcSEcCtD
Sofosbuvir—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000305	0.0013	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000302	0.00129	CcSEcCtD
Sofosbuvir—Skin disorder—Epirubicin—urinary bladder cancer	0.000302	0.00128	CcSEcCtD
Sofosbuvir—Insomnia—Methotrexate—urinary bladder cancer	0.0003	0.00128	CcSEcCtD
Sofosbuvir—Arthralgia—Doxorubicin—urinary bladder cancer	0.0003	0.00128	CcSEcCtD
Sofosbuvir—Chest pain—Doxorubicin—urinary bladder cancer	0.0003	0.00128	CcSEcCtD
Sofosbuvir—Myalgia—Doxorubicin—urinary bladder cancer	0.0003	0.00128	CcSEcCtD
Sofosbuvir—Anxiety—Doxorubicin—urinary bladder cancer	0.000299	0.00127	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000298	0.00127	CcSEcCtD
Sofosbuvir—Dyspnoea—Methotrexate—urinary bladder cancer	0.000296	0.00126	CcSEcCtD
Sofosbuvir—Dry mouth—Doxorubicin—urinary bladder cancer	0.000293	0.00125	CcSEcCtD
Sofosbuvir—Dyspepsia—Methotrexate—urinary bladder cancer	0.000292	0.00124	CcSEcCtD
Sofosbuvir—Decreased appetite—Methotrexate—urinary bladder cancer	0.000288	0.00123	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000287	0.00122	CcSEcCtD
Sofosbuvir—Fatigue—Methotrexate—urinary bladder cancer	0.000286	0.00122	CcSEcCtD
Sofosbuvir—Infection—Doxorubicin—urinary bladder cancer	0.000285	0.00121	CcSEcCtD
Sofosbuvir—Pain—Methotrexate—urinary bladder cancer	0.000284	0.00121	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000283	0.0012	CcSEcCtD
Sofosbuvir—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000282	0.0012	CcSEcCtD
Sofosbuvir—Insomnia—Epirubicin—urinary bladder cancer	0.000281	0.0012	CcSEcCtD
Sofosbuvir—Skin disorder—Doxorubicin—urinary bladder cancer	0.000279	0.00119	CcSEcCtD
Sofosbuvir—Dyspnoea—Epirubicin—urinary bladder cancer	0.000277	0.00118	CcSEcCtD
Sofosbuvir—Dyspepsia—Epirubicin—urinary bladder cancer	0.000273	0.00116	CcSEcCtD
Sofosbuvir—Decreased appetite—Epirubicin—urinary bladder cancer	0.00027	0.00115	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000268	0.00114	CcSEcCtD
Sofosbuvir—Fatigue—Epirubicin—urinary bladder cancer	0.000268	0.00114	CcSEcCtD
Sofosbuvir—Pain—Epirubicin—urinary bladder cancer	0.000266	0.00113	CcSEcCtD
Sofosbuvir—Constipation—Epirubicin—urinary bladder cancer	0.000266	0.00113	CcSEcCtD
Sofosbuvir—Body temperature increased—Methotrexate—urinary bladder cancer	0.000262	0.00112	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000262	0.00111	CcSEcCtD
Sofosbuvir—Insomnia—Doxorubicin—urinary bladder cancer	0.00026	0.00111	CcSEcCtD
Sofosbuvir—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000256	0.00109	CcSEcCtD
Sofosbuvir—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000253	0.00108	CcSEcCtD
Sofosbuvir—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00025	0.00106	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000248	0.00106	CcSEcCtD
Sofosbuvir—Fatigue—Doxorubicin—urinary bladder cancer	0.000248	0.00105	CcSEcCtD
Sofosbuvir—Pain—Doxorubicin—urinary bladder cancer	0.000246	0.00105	CcSEcCtD
Sofosbuvir—Constipation—Doxorubicin—urinary bladder cancer	0.000246	0.00105	CcSEcCtD
Sofosbuvir—Body temperature increased—Epirubicin—urinary bladder cancer	0.000246	0.00104	CcSEcCtD
Sofosbuvir—Asthenia—Methotrexate—urinary bladder cancer	0.000238	0.00101	CcSEcCtD
Sofosbuvir—Pruritus—Methotrexate—urinary bladder cancer	0.000235	0.000999	CcSEcCtD
Sofosbuvir—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000227	0.000967	CcSEcCtD
Sofosbuvir—Diarrhoea—Methotrexate—urinary bladder cancer	0.000227	0.000966	CcSEcCtD
Sofosbuvir—Asthenia—Epirubicin—urinary bladder cancer	0.000223	0.000948	CcSEcCtD
Sofosbuvir—Pruritus—Epirubicin—urinary bladder cancer	0.00022	0.000935	CcSEcCtD
Sofosbuvir—Dizziness—Methotrexate—urinary bladder cancer	0.000219	0.000934	CcSEcCtD
Sofosbuvir—Diarrhoea—Epirubicin—urinary bladder cancer	0.000212	0.000904	CcSEcCtD
Sofosbuvir—Vomiting—Methotrexate—urinary bladder cancer	0.000211	0.000898	CcSEcCtD
Sofosbuvir—Rash—Methotrexate—urinary bladder cancer	0.000209	0.00089	CcSEcCtD
Sofosbuvir—Dermatitis—Methotrexate—urinary bladder cancer	0.000209	0.000889	CcSEcCtD
Sofosbuvir—Headache—Methotrexate—urinary bladder cancer	0.000208	0.000885	CcSEcCtD
Sofosbuvir—Asthenia—Doxorubicin—urinary bladder cancer	0.000206	0.000877	CcSEcCtD
Sofosbuvir—Dizziness—Epirubicin—urinary bladder cancer	0.000205	0.000874	CcSEcCtD
Sofosbuvir—Pruritus—Doxorubicin—urinary bladder cancer	0.000203	0.000865	CcSEcCtD
Sofosbuvir—Vomiting—Epirubicin—urinary bladder cancer	0.000197	0.00084	CcSEcCtD
Sofosbuvir—Nausea—Methotrexate—urinary bladder cancer	0.000197	0.000839	CcSEcCtD
Sofosbuvir—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000197	0.000837	CcSEcCtD
Sofosbuvir—Rash—Epirubicin—urinary bladder cancer	0.000196	0.000833	CcSEcCtD
Sofosbuvir—Dermatitis—Epirubicin—urinary bladder cancer	0.000196	0.000832	CcSEcCtD
Sofosbuvir—Headache—Epirubicin—urinary bladder cancer	0.000195	0.000828	CcSEcCtD
Sofosbuvir—Dizziness—Doxorubicin—urinary bladder cancer	0.00019	0.000809	CcSEcCtD
Sofosbuvir—Nausea—Epirubicin—urinary bladder cancer	0.000184	0.000785	CcSEcCtD
Sofosbuvir—Vomiting—Doxorubicin—urinary bladder cancer	0.000183	0.000777	CcSEcCtD
Sofosbuvir—Rash—Doxorubicin—urinary bladder cancer	0.000181	0.000771	CcSEcCtD
Sofosbuvir—Dermatitis—Doxorubicin—urinary bladder cancer	0.000181	0.00077	CcSEcCtD
Sofosbuvir—Headache—Doxorubicin—urinary bladder cancer	0.00018	0.000766	CcSEcCtD
Sofosbuvir—Nausea—Doxorubicin—urinary bladder cancer	0.000171	0.000726	CcSEcCtD
